Remove Angina Remove Cholesterol Remove Sudden Cardiac Death
article thumbnail

Lowering Atherosclerotic Cardiovascular Disease Events by Treating Residual Inflammatory Risk

DAIC

Inflammation driven by signaling cytokines, circulating immune cells, adhesion molecules, and oxidized low-density lipoprotein cholesterol (LDL-C) leads to atherosclerotic plaque development, plaque progression, and eventual rupture.14,15 21 Luckily, each of these risks can be measured by simple blood tests. 12 Importantly, colchicine, 0.5

article thumbnail

The “open data” movement runs aground on FOURIER

Dr. Anish Koka

Discovering discrepancies in a major published trial from the pharma-academic complex would be a boost to those seeking to force trial data to be public, and that is exactly what a group of investigators attempted to do with a major cholesterol lowering trial published in 2017. Cholesterol lowering is big business.